Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription


3 AIDS Res Hum Retroviruses
1 Arch Dis Child
1 Clin Infect Dis
2 J Acquir Immune Defic Syndr
4 J Infect Dis
1 J Med Virol
2 Lancet
2 Lancet Public Health
1 Pediatr Infect Dis J
1 PLoS Genet
1 PLoS Med
7 PLoS One
1 Proc Natl Acad Sci U S A


  1. DUNCAN CJA, Charlton FG, Bower M, Price DA, et al
    The unholy trinity of human herpesvirus 8-associated malignancy in a person living with HIV-1.
    AIDS. 2018;32:404-406.
    >> Share

  2. MINGUEZ C, Garcia-Deltoro M, Flores J, Galindo MJ, et al
    Interferon-free therapy for treating hepatitis C virus in difficult-to-treat HIV-coinfected patients.
    AIDS. 2018;32:337-346.
    >> Share

    AIDS Res Hum Retroviruses

  3. PESCATORE N, Pollak R, Kraft C, Mulle J, et al
    Anatomic Site of Sampling and the Rectal Mucosal Microbiota in HIV negative MSM engaging in CRAI.
    AIDS Res Hum Retroviruses. 2018 Jan 7. doi: 10.1089/AID.2017.0206.
    >> Share

  4. BUCHACZ K, Armon C, Tedaldi E, Palella FJ, et al
    Disparities in HIV Viral Load Suppression by Race/ethnicity among Men who Have Sex with Men in the HIV Outpatient Study.
    AIDS Res Hum Retroviruses. 2018 Jan 9. doi: 10.1089/AID.2017.0162.
    >> Share

  5. BRUZZONE B, Canepa P, De Rosa G, Delucis S, et al
    Correct Identification of Dual HCV Infections in HIV/HCV CoInfected Patients.
    AIDS Res Hum Retroviruses. 2018 Jan 9. doi: 10.1089/aid.2017.0133.
    >> Share

    Arch Dis Child

  6. LANG'AT PC, Ogada I, Steenbeek A, MacDonald NE, et al
    Infant feeding practices among HIV-exposed infants less than 6 months of age in Bomet County, Kenya: an in-depth qualitative study of feeding choices.
    Arch Dis Child. 2018 Jan 9. pii: archdischild-2017-314521.
    >> Share

    Clin Infect Dis

  7. COLE JH, Caan MWA, Underwood J, De Francesco D, et al
    No evidence for accelerated ageing-related brain pathology in treated HIV: longitudinal neuroimaging results from the Comorbidity in Relation to AIDS (COBRA) project.
    Clin Infect Dis. 2018 Jan 4. pii: 4788363. doi: 10.1093/cid/cix1124.
    >> Share

    J Acquir Immune Defic Syndr

  8. O'BRYAN TA, Agan BK, Tracy RP, Freiberg MS, et al
    Racial Comparison of D-dimer Levels in U.S. Male Military Personnel Before and After HIV Infection and Viral Suppression.
    J Acquir Immune Defic Syndr. 2018 Jan 8. doi: 10.1097/QAI.0000000000001626.
    >> Share

  9. DE BENEDETTO I, Masetti M, Fabbiani M, Biasin M, et al
    Higher Levels of Peripheral Th17 T Cd4+ Cells are Associated With Immunological Non-Response in Hiv-Infected Patients Undereffective Art.
    J Acquir Immune Defic Syndr. 2018 Jan 8. doi: 10.1097/QAI.0000000000001627.
    >> Share

    J Infect Dis

  10. KOOIJ KW, Vogt L, Reiss P
    Reply to Moso et al.
    J Infect Dis. 2017 Dec 22. pii: 4772651. doi: 10.1093.
    >> Share

  11. ANGELIDOU K, Hunt PW, Landay AL, Wilson CC, et al
    Changes in inflammation but not in T cell activation precede non-AIDS-defining events in a case-control study of patients on long-term antiretroviral therapy.
    J Infect Dis. 2017 Dec 22. pii: 4772233. doi: 10.1093.
    >> Share

  12. TANSEY C, Zhao C, Hopkins A, Ritter JM, et al
    A Non-human Primate Model for Rectally Transmitted Syphilis.
    J Infect Dis. 2017 Dec 22. pii: 4772175. doi: 10.1093.
    >> Share

  13. MOSO MA, Woolnough E, Langham F, Hoy JF, et al
    Increasing prevalence and risk of chronic kidney disease in HIV-positive individuals: changing demographics over a six-year period.
    J Infect Dis. 2017 Dec 22. pii: 4772637. doi: 10.1093.
    >> Share

    J Med Virol

  14. MARIO S, Carmine M, Stefania P, Margherita M, et al
    J Med Virol. 2018 Jan 9. doi: 10.1002/jmv.25022.
    >> Share


  15. GREEN MJ, Squier SM
    Graphic Medicine: The Best of 2017.
    JAMA. 2017;318:2280-2281.
    >> Share

  16. RUBIN R
    Nearly 15% of US HIV Infections Undiagnosed in 2015.
    JAMA. 2018;319:114.
    >> Share


  17. LLIBRE JM, Hung CC, Brinson C, Castelli F, et al
    Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies.
    Lancet. 2018 Jan 5. pii: S0140-6736(17)33095.
    >> Share

  18. BICCARD BM, Madiba TE, Kluyts HL, Munlemvo DM, et al
    Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study.
    Lancet. 2018 Jan 3. pii: S0140-6736(18)30001.
    >> Share

    Lancet Public Health

  19. MADISE NJ, Onyango B
    Protecting female migrants from forced sex and HIV infection.
    Lancet Public Health. 2018;3:e2-e3.
    >> Share

  20. PANNETIER J, Ravalihasy A, Lydie N, Lert F, et al
    Prevalence and circumstances of forced sex and post-migration HIV acquisition in sub-Saharan African migrant women in France: an analysis of the ANRS-PARCOURS retrospective population-based study.
    Lancet Public Health. 2018;3:e16-e23.
    >> Share

    Pediatr Infect Dis J

  21. BESTE S, Essajee S, Siberry G, Hannaford A, et al
    Optimal Antiretroviral Prophylaxis in Infants at High Risk of Acquiring HIV: A Systematic Review.
    Pediatr Infect Dis J. 2018;37:169-175.
    >> Share

    PLoS Genet

  22. ZACKAY A, Cotton JA, Sanders M, Hailu A, et al
    Genome wide comparison of Ethiopian Leishmania donovani strains reveals differences potentially related to parasite survival.
    PLoS Genet. 2018;14:e1007133.
    >> Share

    PLoS Med

  23. MARRAZZO JM, Dombrowski JC, Mayer KH
    Sexually transmitted infections in the era of antiretroviral-based HIV prevention: Priorities for discovery research, implementation science, and community involvement.
    PLoS Med. 2018;15:e1002485.
    >> Share

    PLoS One

  24. BAXI SM, Vittinghoff E, Bacchetti P, Huang Y, et al
    Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial.
    PLoS One. 2018;13:e0190118.
    >> Share

  25. BIVIGOU-MBOUMBA B, Amougou-Atsama M, Zoa-Assoumou S, M'boyis Kamdem H, et al
    Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence.
    PLoS One. 2018;13:e0190592.
    >> Share

  26. TONEN-WOLYEC S, Batina-Agasa S, Muwonga J, Fwamba N'kulu F, et al
    Evaluation of the practicability and virological performance of finger-stick whole-blood HIV self-testing in French-speaking sub-Saharan Africa.
    PLoS One. 2018;13:e0189475.
    >> Share

  27. AVONG YK, Aliyu GG, Jatau B, Gurumnaan R, et al
    Integrating community pharmacy into community based anti-retroviral therapy program: A pilot implementation in Abuja, Nigeria.
    PLoS One. 2018;13:e0190286.
    >> Share

  28. AUGUSTEMAK DE LIMA LR, Petroski EL, Moreno YMF, Silva DAS, et al
    Dyslipidemia, chronic inflammation, and subclinical atherosclerosis in children and adolescents infected with HIV: The PositHIVe Health Study.
    PLoS One. 2018;13:e0190785.
    >> Share

  29. CARIMO AA, Gudo ES, Maueia C, Mabunda N, et al
    First report of occult hepatitis B infection among ART naive HIV seropositive individuals in Maputo, Mozambique.
    PLoS One. 2018;13:e0190775.
    >> Share

  30. GONZALEZ-DOMENECH CM, Viciana I, Delaye L, Mayorga ML, et al
    Emergence as an outbreak of the HIV-1 CRF19_cpx variant in treatment-naive patients in southern Spain.
    PLoS One. 2018;13:e0190544.
    >> Share

    Proc Natl Acad Sci U S A

  31. LOUIE RHY, Kaczorowski KJ, Barton JP, Chakraborty AK, et al
    Fitness landscape of the human immunodeficiency virus envelope protein that is targeted by antibodies.
    Proc Natl Acad Sci U S A. 2018 Jan 8. pii: 1717765115.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016